Momelotinib for myelofibrosis: 12-year survival data and retrospective comparison to ruxolitinib.
Ayalew TefferiAnimesh D PardananiKebede H BegnaAref A Al-KaliWilliam J HoganMark R LitzowCurtis A HansonRhett P KetterlingNaseema GangatPublished in: American journal of hematology (2022)